FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367722744> ?p ?o ?g. }

• W4367722744 endingPage "20" @default.
• W4367722744 startingPage "12" @default.
• W4367722744 abstract "Summary. The aim of our study was to determine the clinical and neurophisiological effectiveness of transcranial magnetic stimulation treatment in patients with stage II Parkinson's disease (PD). Materials and methods. The prospective randomised placebo-controlled study included 90 patients aged 49 to 75 years with stage II PD according to Hoehn-Yahr. All patients were randomized to two groups of 45 in each for a TMS course: group 1 included patients assigned to a real TMS course, while group 2 included placebo TMS sessions. All patients on the background of basic PD therapy were additionally prescribed a course of therapeutic TMS sessions according to the protocol in zones C3, C4 and Cz of the brain (projection of the premotor cortex according to the international system 10-20%) with a pulse frequency in the series of 5 Hz and a total number of pulses of 2000 per session. During the study, patients were examined twice: at the beginning and at the end of TMS sessions. Examination of patients was performed according to the following scheme: clinical and neurological examination using SPES SCOPA Motor scale and neurophysiological examination to determine the latency, amplitude, area and duration of motor evoked potential (MEP) after 2 tests with a gradual increase of magnetic field induction. Results. TMS treatment resulted in a significant reduction in MEP latency (p<0,001) in patients from with real TMS group, while it was found no reduction in MEP latency (p> 0,05) in placebo-TMS patients. The amplitude of the MEP of the left and right premotor cortex did not change significantly either in the group with real TMS (p>0,05) or in the group of placebo-TMS (p>0,05). The duration of MEP increased significantly (p <0,001) after the course of TMS, and in the placebo-TMS group no significant changes were found (p> 0,05). Conclusions. Treatment with TMS leads to a clinical reduction in the manifestations of motor symptoms of PD using the SPES SCOPA Motor scale score, namely to a decrease in the amplitude of rest and postural tremor, bradykinesia, rigidity and gait disorders. Also TMS leads to a significant decrease in the latent period of MEP and increase the duration of MEP." @default.
• W4367722744 created "2023-05-04" @default.
• W4367722744 creator A5078432038 @default.
• W4367722744 date "2022-07-01" @default.
• W4367722744 modified "2023-09-27" @default.
• W4367722744 title "Clinical and neurophysiologival efficacy of transcranial magnetic stimulation treatment in patients with stage II Parkinson's disease" @default.
• W4367722744 cites W1441164701 @default.
• W4367722744 cites W1726896534 @default.
• W4367722744 cites W2123250288 @default.
• W4367722744 cites W2145066872 @default.
• W4367722744 cites W2175485468 @default.
• W4367722744 cites W2315107302 @default.
• W4367722744 cites W2616447787 @default.
• W4367722744 cites W2637633626 @default.
• W4367722744 cites W2808049432 @default.
• W4367722744 cites W2893025570 @default.
• W4367722744 cites W2943687320 @default.
• W4367722744 cites W2979648851 @default.
• W4367722744 cites W3008298710 @default.
• W4367722744 doi "https://doi.org/10.26565/2617-409x-2022-9-02" @default.
• W4367722744 hasPublicationYear "2022" @default.
• W4367722744 type Work @default.
• W4367722744 citedByCount "0" @default.
• W4367722744 crossrefType "journal-article" @default.
• W4367722744 hasAuthorship W4367722744A5078432038 @default.
• W4367722744 hasBestOaLocation W43677227441 @default.
• W4367722744 hasConcept C126322002 @default.
• W4367722744 hasConcept C142724271 @default.
• W4367722744 hasConcept C15744967 @default.
• W4367722744 hasConcept C1862650 @default.
• W4367722744 hasConcept C204787440 @default.
• W4367722744 hasConcept C24998067 @default.
• W4367722744 hasConcept C27081682 @default.
• W4367722744 hasConcept C2778373776 @default.
• W4367722744 hasConcept C2778581513 @default.
• W4367722744 hasConcept C2778823896 @default.
• W4367722744 hasConcept C42219234 @default.
• W4367722744 hasConcept C535046627 @default.
• W4367722744 hasConcept C548259974 @default.
• W4367722744 hasConcept C71924100 @default.
• W4367722744 hasConceptScore W4367722744C126322002 @default.
• W4367722744 hasConceptScore W4367722744C142724271 @default.
• W4367722744 hasConceptScore W4367722744C15744967 @default.
• W4367722744 hasConceptScore W4367722744C1862650 @default.
• W4367722744 hasConceptScore W4367722744C204787440 @default.
• W4367722744 hasConceptScore W4367722744C24998067 @default.
• W4367722744 hasConceptScore W4367722744C27081682 @default.
• W4367722744 hasConceptScore W4367722744C2778373776 @default.
• W4367722744 hasConceptScore W4367722744C2778581513 @default.
• W4367722744 hasConceptScore W4367722744C2778823896 @default.
• W4367722744 hasConceptScore W4367722744C42219234 @default.
• W4367722744 hasConceptScore W4367722744C535046627 @default.
• W4367722744 hasConceptScore W4367722744C548259974 @default.
• W4367722744 hasConceptScore W4367722744C71924100 @default.
• W4367722744 hasIssue "9" @default.
• W4367722744 hasLocation W43677227441 @default.
• W4367722744 hasOpenAccess W4367722744 @default.
• W4367722744 hasPrimaryLocation W43677227441 @default.
• W4367722744 hasRelatedWork W1990699520 @default.
• W4367722744 hasRelatedWork W2008296954 @default.
• W4367722744 hasRelatedWork W2081395287 @default.
• W4367722744 hasRelatedWork W2116848521 @default.
• W4367722744 hasRelatedWork W2172037535 @default.
• W4367722744 hasRelatedWork W2397278289 @default.
• W4367722744 hasRelatedWork W2417017409 @default.
• W4367722744 hasRelatedWork W2883570850 @default.
• W4367722744 hasRelatedWork W2884528379 @default.
• W4367722744 hasRelatedWork W3136364654 @default.
• W4367722744 isParatext "false" @default.
• W4367722744 isRetracted "false" @default.
• W4367722744 workType "article" @default.